Sope O. Olugbile
Expertise in
31
conditions

Dr. Sope O. Olugbile

Oncology
1800 Howell Mill Road Suite 300, 
Atlanta, GA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
31
conditions
1800 Howell Mill Road Suite 300, 
Atlanta, GA 

Overview

Sope Olugbile, MD, is board certified in internal medicine and medical oncology. He treats lung, head/neck, esophageal, gastric, skin, prostate, bladder, kidney, sarcoma and other rare cancers, with a special interest in precision medicine (targeted therapy), immuno-oncology (immunotherapy), bispecific antibodies, clinical trials and cellular therapy.In his spare time, he enjoys spending time and travelling with family.Dr. Olugbile welcomes new patients and accepts most major insurance plans.

Dr. Olugbile is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, Large-Cell Lung Carcinoma, and Non-Small Cell Lung Cancer (NSCLC).

Dr. Olugbile is board certified in American Board Of Internal Medicine - Medical Oncology and American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 6 peer reviewed articles and participating in 1 clinical trial. Dr. Olugbile is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in CT

Board Certifications

American Board Of Internal Medicine - Medical Oncology
American Board Of Internal Medicine

Fellowships

University of Chicago, Hematology and Medical Oncology, 2017

Hospital Affiliations

Piedmont Eastside Medical Center
Hartford Hospital
Piedmont Newnan Hospital, Inc
Piedmont Hospital, Inc
William W Backus Hospital

Languages Spoken

English
Yoruba

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health New England
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Piedmont Physicians Medical Oncology Atlanta
1800 Howell Mill Road Suite 300, Atlanta, GA 30318

Additional Areas of Focus

Dr. Olugbile has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma
Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Phase 1 Multicenter, Open-Label, Dose Escalation Study and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of STP705 Administered Intratumorally in Cholangiocarcinoma, Hepatocellular Carcinoma or Liver Metastases in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy
Phase 1 Multicenter, Open-Label, Dose Escalation Study and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of STP705 Administered Intratumorally in Cholangiocarcinoma, Hepatocellular Carcinoma or Liver Metastases in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy
Enrollment Status: Completed
Publish Date: March 19, 2024
Intervention Type: Drug
Study Drug: STP705
Study Phase: Phase 1

6 Total Publications

Cross-reactivity of rPvs48/45, a recombinant Plasmodium vivax protein, with plasma from Plasmodium falciparum endemic areas of Africa.
Cross-reactivity of rPvs48/45, a recombinant Plasmodium vivax protein, with plasma from Plasmodium falciparum endemic areas of Africa.
Journal: PloS one
Published: May 07, 2024
Similar Doctors
Expertise in
5
conditions
Dr. Carlton D. Dampier
Hematology | Oncology
Expertise in
5
conditions
Dr. Carlton D. Dampier
Hematology | Oncology
Referral may be required

Children's Healthcare Of Atlanta At Hughes Spalding

35 Jesse Hill Jr Dr SE, 
Atlanta, GA 
 (4.7 miles away)
404-785-9800
Languages Spoken:
English, French, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Carlton Dampier is a Hematologist and an Oncologist practicing medicine in Atlanta, Georgia. Dr. Dampier is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia. Dr. Dampier is currently accepting new patients.

Expertise in
17
conditions
Expertise in
17
conditions
Referral may be required
Before you request

Emory Winship Cancer Institute

1365 Clifton Road Northeast, BldgC, 
Atlanta, GA 
 (7.0 miles away)
404-778-1900
Languages Spoken:
English, Tamil
See accepted insurances
Accepting New Patients
Offers Telehealth

Suresh Ramalingam is an Oncologist practicing medicine in Atlanta, Georgia. Dr. Ramalingam is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Ramalingam is board certified in American Board Of Internal Medicine, 2003. Dr. Ramalingam is currently accepting new patients.

Expertise in
27
conditions
Expertise in
27
conditions
Referral may be required
Before you request

Emory Winship Cancer Institute

1365 Clifton Road Northeast, BldgC, 
Atlanta, GA 
 (7.0 miles away)
404-778-1900
Languages Spoken:
English, Mandarin, Spanish, Turkish
See accepted insurances
Accepting New Patients
Offers Telehealth

Mehmet Bilen is an Oncologist practicing medicine in Atlanta, Georgia. Dr. Bilen is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Urothelial Cancer, Nephrectomy, and Tissue Biopsy. Dr. Bilen is board certified in American Board Of Internal Medicine, 2016. Dr. Bilen is currently accepting new patients.

Frequently Asked Questions about Dr. Sope O. Olugbile

How do I make an appointment with Dr. Sope O. Olugbile?

You can book an appointment with Dr. Sope O. Olugbile by calling their office at 404-425-1777. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Sope O. Olugbile a top-rated expert for Small Cell Lung Cancer (SCLC)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sope O. Olugbile is classified as an Distinguished expert for Small Cell Lung Cancer (SCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Sope O. Olugbile specialize in?

While Dr. Sope O. Olugbile is a Oncology, they have specific expertise in Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, and Large-Cell Lung Carcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Sope O. Olugbile participate in research or clinical trials?

Yes. Dr. Sope O. Olugbile has published 6 articles and abstracts on conditions like Small Cell Lung Cancer (SCLC). You can view a list of Dr. Sope O. Olugbile's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Sope O. Olugbile accept my insurance?

Dr. Sope O. Olugbile accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 404-425-1777 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Olugbile's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 24 Advanced Conditions
    View All 90 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile